Cytarabine (Pfizer Laboratories Div Pfizer Inc.)
Welcome to the PulseAid listing for the Cytarabine drug offered from Pfizer Laboratories Div Pfizer Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc. |
NON-PROPRIETARY NAME: | Cytarabine |
SUBSTANCE NAME: | CYTARABINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-12-14 |
END MARKETING DATE: | 0000-00-00 |
Cytarabine HUMAN PRESCRIPTION DRUG Details:
Item Description | Cytarabine from Pfizer Laboratories Div Pfizer Inc. |
LABELER NAME: | Pfizer Laboratories Div Pfizer Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/5mL) |
START MARKETING DATE: | 2011-12-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0069-0152_c296d15c-df78-49e7-b55a-ff070822fdf9 |
PRODUCT NDC: | 0069-0152 |
APPLICATION NUMBER: | ANDA200915 |
Other CYTARABINE Pharmaceutical Manufacturers / Labelers: